Evidence map›Paper›PMID 38891856›Full record

ArticleInternational journal of molecular sciences2024

Preclinical Evaluation of Biodistribution and Toxicity of [

Tadashi Watabe, Kazuko Kaneda-Nakashima, Yuichiro Kadonaga, Kazuhiro Ooe, Thosapol Sampunta, Naoki Hirose, Xiaojie Yin, Hiromitsu Haba, Yukiyoshi Kon, Atsushi Toyoshima and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Effective treatment of human prostate carcinoma xenografts with Single-Dose PSMA-targeted [European journal of nuclear medicine and molecular imaging · 2026
    Article
  2. Review
  3. Scale-up production of [EJNMMI radiopharmacy and chemistry · 2025
    Article
  4. Theranostic Application of Radiohalogens in Nuclear Medicine.Nuclear medicine and molecular imaging · 2025
    Review
  5. LAT1-Targeted Alpha Therapy UsingInternational journal of molecular sciences · 2025
    Article
  6. Recent Advances in Anti-Cancer Drugs.International journal of molecular sciences · 2025
    Article
  7. Review
  8. Review
  9. AnEuropean journal of nuclear medicine and molecular imaging · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Tadashi WatabeDepartment of Radiology, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan.ORCID 0000-0001-8658-2395
Kazuko Kaneda-NakashimaInstitute for Radiation Sciences, Osaka University, Osaka 565-0871, Japan.ORCID 0000-0001-6657-5059
Yuichiro KadonagaInstitute for Radiation Sciences, Osaka University, Osaka 565-0871, Japan.
Kazuhiro OoeInstitute for Radiation Sciences, Osaka University, Osaka 565-0871, Japan.
Thosapol SampuntaDepartment of Radiology, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan.
Naoki HiroseInstitute of Experimental Animal Sciences, Faculty of Medicine, Osaka University, Osaka 565-0871, Japan.ORCID 0000-0002-3358-0916
Xiaojie YinNishina Center for Accelerator-Based Science, RIKEN, Wako 351-0198, Japan.
Hiromitsu HabaNishina Center for Accelerator-Based Science, RIKEN, Wako 351-0198, Japan.
Yukiyoshi KonInstitute for Radiation Sciences, Osaka University, Osaka 565-0871, Japan.
Atsushi ToyoshimaInstitute for Radiation Sciences, Osaka University, Osaka 565-0871, Japan.
Jens CardinaleDepartment of Nuclear Medicine, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf, 40225 Duesseldorf, Germany.ORCID 0000-0001-6558-966X
Frederik L GieselInstitute for Radiation Sciences, Osaka University, Osaka 565-0871, Japan.
Koichi FukaseInstitute for Radiation Sciences, Osaka University, Osaka 565-0871, Japan.ORCID 0000-0001-8844-0710
Noriyuki TomiyamaDepartment of Radiology, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan.
Yoshifumi ShirakamiInstitute for Radiation Sciences, Osaka University, Osaka 565-0871, Japan.ORCID 0000-0003-2352-9057

Funding

Japan Agency for Medical Research and Development JP23ym0126091
6 · The paper itself

Abstract

Astatine (

Indexed as

Prostatic NeoplasmsAlpha ParticlesAnimalsAstatineGlutamate Carboxypeptidase IIHumansMacaca fascicularisMaleMiceMice, Inbred ICRRadiopharmaceuticalsTissue DistributionAstatineGlutamate Carboxypeptidase IIRadiopharmaceuticalsastatineclinical trialprostate cancerPSMAtoxicity study

Identifiers

PMID38891856
PMCPMC11172375

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.